CAMBRIDGE, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate virtually in B. Riley Securities’ 3rd Annual Oncology Conference.
B. Riley Securities’ 3rd Annual Oncology Conference – Fireside Chat
Date: Wednesday, January 18, 2023
Time: 12:00 PM ET
A live webcast of the presentation will be available via the Investors section of the Company's website at www.vorbio.com . An archived replay of the webcast will also be available following the conference.
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com .
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com